These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 30118769)
21. Computational Strategy for Bound State Structure Prediction in Structure-Based Virtual Screening: A Case Study of Protein Tyrosine Phosphatase Receptor Type O Inhibitors. Hou X; Rooklin D; Yang D; Liang X; Li K; Lu J; Wang C; Xiao P; Zhang Y; Sun JP; Fang H J Chem Inf Model; 2018 Nov; 58(11):2331-2342. PubMed ID: 30299094 [TBL] [Abstract][Full Text] [Related]
22. Binding mechanism of spinosine and venenatine molecules with p300 HAT enzyme: Molecular screening, molecular dynamics and free-energy analysis. Magudeeswaran S; Poomani K J Cell Biochem; 2020 Feb; 121(2):1759-1777. PubMed ID: 31633226 [TBL] [Abstract][Full Text] [Related]
23. An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity. El Turk F; Fauvet B; Ouertatani-Sakouhi H; Lugari A; Betzi S; Roche P; Morelli X; Lashuel HA Bioorg Med Chem; 2010 Jul; 18(14):5425-40. PubMed ID: 20639113 [TBL] [Abstract][Full Text] [Related]
24. Differential Effects of Histone Acetyltransferase GCN5 or PCAF Knockdown on Urothelial Carcinoma Cells. Koutsogiannouli EA; Wagner N; Hader C; Pinkerneil M; Hoffmann MJ; Schulz WA Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28678170 [TBL] [Abstract][Full Text] [Related]
25. Reactivity of isothiazolones and isothiazolone-1-oxides in the inhibition of the PCAF histone acetyltransferase. Ghizzoni M; Haisma HJ; Dekker FJ Eur J Med Chem; 2009 Dec; 44(12):4855-61. PubMed ID: 19683843 [TBL] [Abstract][Full Text] [Related]
26. In-silico identification of inhibitors against mutated BCR-ABL protein of chronic myeloid leukemia: a virtual screening and molecular dynamics simulation study. Kumar H; Raj U; Gupta S; Varadwaj PK J Biomol Struct Dyn; 2016 Oct; 34(10):2171-83. PubMed ID: 26479578 [TBL] [Abstract][Full Text] [Related]
27. Energy-Based Pharmacophore and Three-Dimensional Quantitative Structure--Activity Relationship (3D-QSAR) Modeling Combined with Virtual Screening To Identify Novel Small-Molecule Inhibitors of Silent Mating-Type Information Regulation 2 Homologue 1 (SIRT1). Pulla VK; Sriram DS; Viswanadha S; Sriram D; Yogeeswari P J Chem Inf Model; 2016 Jan; 56(1):173-87. PubMed ID: 26636371 [TBL] [Abstract][Full Text] [Related]
28. Discovery of 1,8-acridinedione derivatives as novel GCN5 inhibitors via high throughput screening. Xiong H; Han J; Wang J; Lu W; Wang C; Chen Y; Fulin Lian ; Zhang N; Liu YC; Zhang C; Ding H; Jiang H; Lu W; Luo C; Zhou B Eur J Med Chem; 2018 May; 151():740-751. PubMed ID: 29665527 [TBL] [Abstract][Full Text] [Related]
29. Discovery of Potent Inhibitors for the Inhibition of Dengue Envelope Protein: An In Silico Approach. Aarthy M; Singh SK Curr Top Med Chem; 2018; 18(18):1585-1602. PubMed ID: 30360716 [TBL] [Abstract][Full Text] [Related]
30. Identification of potent inhibitors of DNA methyltransferase 1 (DNMT1) through a pharmacophore-based virtual screening approach. Krishna S; Shukla S; Lakra AD; Meeran SM; Siddiqi MI J Mol Graph Model; 2017 Aug; 75():174-188. PubMed ID: 28582695 [TBL] [Abstract][Full Text] [Related]
31. Structural insights on identification of potential lead compounds targeting WbpP in Vibrio vulnificus through structure-based approaches. Sasikala D; Jeyakanthan J; Srinivasan P J Recept Signal Transduct Res; 2016 Oct; 36(5):515-30. PubMed ID: 26795501 [TBL] [Abstract][Full Text] [Related]
32. Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation. Szelag M; Czerwoniec A; Wesoly J; Bluyssen HA PLoS One; 2015; 10(2):e0116688. PubMed ID: 25710482 [TBL] [Abstract][Full Text] [Related]
33. Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical Probe. Humphreys PG; Bamborough P; Chung CW; Craggs PD; Gordon L; Grandi P; Hayhow TG; Hussain J; Jones KL; Lindon M; Michon AM; Renaux JF; Suckling CJ; Tough DF; Prinjha RK J Med Chem; 2017 Jan; 60(2):695-709. PubMed ID: 28002667 [TBL] [Abstract][Full Text] [Related]
35. Dissociable roles for histone acetyltransferases p300 and PCAF in hippocampus and perirhinal cortex-mediated object memory. Mitchnick KA; Creighton SD; Cloke JM; Wolter M; Zaika O; Christen B; Van Tiggelen M; Kalisch BE; Winters BD Genes Brain Behav; 2016 Jul; 15(6):542-57. PubMed ID: 27251651 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological testing of novel pyridoisothiazolones as histone acetyltransferase inhibitors. Furdas SD; Shekfeh S; Bissinger EM; Wagner JM; Schlimme S; Valkov V; Hendzel M; Jung M; Sippl W Bioorg Med Chem; 2011 Jun; 19(12):3678-89. PubMed ID: 21353783 [TBL] [Abstract][Full Text] [Related]
37. Identification of potential glutaminyl cyclase inhibitors from lead-like libraries by in silico and in vitro fragment-based screening. Szaszkó M; Hajdú I; Flachner B; Dobi K; Magyar C; Simon I; Lőrincz Z; Kapui Z; Pázmány T; Cseh S; Dormán G Mol Divers; 2017 Feb; 21(1):175-186. PubMed ID: 28070724 [TBL] [Abstract][Full Text] [Related]
38. Fluorescence analysis of a dynamic loop in the PCAF/GCN5 histone acetyltransferase. Zheng Y; Mamdani F; Toptygin D; Brand L; Stivers JT; Cole PA Biochemistry; 2005 Aug; 44(31):10501-9. PubMed ID: 16060659 [TBL] [Abstract][Full Text] [Related]
39. The p300/CBP-associated factor (PCAF) is a cofactor of ATF4 for amino acid-regulated transcription of CHOP. Chérasse Y; Maurin AC; Chaveroux C; Jousse C; Carraro V; Parry L; Deval C; Chambon C; Fafournoux P; Bruhat A Nucleic Acids Res; 2007; 35(17):5954-65. PubMed ID: 17726049 [TBL] [Abstract][Full Text] [Related]
40. Screening of Potential Lead Molecule as Novel MurE Inhibitor: Virtual Screening, Molecular Dynamics and In Vitro Studies. Zaveri K; Kiranmayi P Curr Comput Aided Drug Des; 2017; 13(1):8-21. PubMed ID: 27748170 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]